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Abstract
Metoprolol succinate is a widely used medication for the management of hypertension, heart
failure, and angina. We report the case of a 36-year-old woman who developed erythema
multiforme after administration of a low dose of this drug. She also presented with pruritic
burning pain throughout her body accompanied by chills. While erythema multiforme has been
reported with carvedilol, this is the first observation of metoprolol succinate causing this and
physicians should be aware of this potential, yet rare, side-effect. (Cardiol J 2009; 16: 82–83)
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A 36-year-old African-American woman with
past medical history significant for pulmonary em-
bolism diagnosed in 2003 in the setting of a left foot
surgical operation, and a recent non-ST elevation
myocardial infarction, presented to the cardiology
clinic with a new rash after initiating metoprolol suc-
cinate.
About one month earlier the patient was admit-
ted to the hospital with a nonradiating substernal
chest pain associated with dyspnea and nausea. The
left heart catherization showed a severely depres-
sed ejection fraction moderate to severe disease
throughout the left anterior descending and circum-
flex arteries. Given that no culprit lesion was iden-
tified, medical therapy was initiated to manage the
coronary disease and the new onset cardiomyopa-
thy. She was discharged with carvedilol, spirono-
lactone, clopidogrel, lisinopril, niacin, simvastatin,
and warfarin. A week later, she was seen in the clinic
with nausea, vomiting, and flushing. She was told
by her primary care physician to stop all medications
except warfarin. The patient was subsequently seen
in the emergency department for intravenous
hydration, and her symptoms resolved. During her
next cardiology visit, clopidogrel, aspirin, and sim-
vastatin were restarted.
After tolerating these medications for about
a week, metoprolol succinate 12.5 mg once a day
was initiated. About three days later, the patient
presented with pruritic burning pain throughout her
body accompanied by chills, but no fever. No dys-
phagia or visual changes were noted. The rash was
erythematous annular macules. Some lesions were
oedematous and slightly raised due to scratching.
No vesicle or bulla was noted. It involved the neck,
chest, abdomen, back and bilateral extremities inc-
luding the palms and soles. No ocular or oral muco-
sal involvement was noted.
She was seen urgently at a dermatology clinic
the same day and diagnosed with erythema multi-
forme. She was given oral hydroxyzine with good
symptom relief. After two days of therapy and
discontinuing metoprolol, trace lesions were visi-
ble on bilateral palms only (Fig. 1) and it comple-
tely resolved in 5 days. No biopsy was taken be-
cause the presentation, lesions and the response
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to the therapy were consistent with erythema mul-
tiforme.
Erythema multiforme (EM), described as con-
centric “target” lesions, can be caused by infections,
autoimmune disease, neoplasms, drugs, or medica-
tions. Although EM is considered to be a self-limi-
ting condition, it overlaps with a more severe va-
riant: Stevens Johnson syndrome. The pathophy-
siology is not clearly known although it has been
shown that 43% of the cases of EM, Stevens John-
son syndrome, and toxic epidermal necrolysis that
are severe enough to require hospitalization are
caused by drug reaction. The common culprits are
phenobarbital, nitrofurantoin, trimethoprim/sulfa-
methoxazole and ampicillin [1]. A previous case
report showed that carvedilol, a beta1, and alpha1
blocker have been associated with Stevens-Johnson
syndrome [2]. Although EM is not associated with
significant mortality and usually resolves in 2 to
4 weeks, it has not been previously reported as an
adverse side effect.
Metoprolol succinate (Toprol XL) is a widely
used medication in the management of hyperten-
sion, heart failure, and angina. More common ad-
verse effects of the medication are fatigue, depres-
sion, and syncope. Although some rashes, such as
worsening psoriasis, have been reported in previo-
us reports, serious side effects involving skin are
rare [3].  This is the first observation of metoprolol
succinate causing erythema multiforme, and phy-
sicians should be aware of this potential rare side
effect.
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Figure 1. Resolving erythema multiforme seen in the
R palm after two days of therapy with hydroxyzine.
